Category: Off-label Promotion

07/28/2014

Doctor Tells Congress That Communication Is Hampered by FDA, CMS Practices

07/14/2014

Kamp to Washington Post: Companies Should Be Able to Speak Truthfully About Drugs

06/03/2014

House Committee Seeks Patient Input on Availability of Treatments

05/22/2014

New Yorker Article Weighs Sales Rep Free Speech Arguments in Off-label Context

05/19/2014

WLF: FDA’s Revised Reprint Draft Guidance Violates Injunction and First Amendment

04/28/2014

FDA Willing to “Re-examine” Off-label Policies in Light of First Amendment Rulings

03/31/2014

Kamp to WSJ: FDA Could Do a Better Job of Defending Off-label Limits

01/27/2014

Caronia Decision One Year Later: Off-label Change May Be Slow, But It’s Brewing

01/08/2014

CHC Briefing to Provide Medical Marketers With Preview of How Washington Will Affect Their 2014